Byetta & Pancreatic Cancer

Helping people who have suffered Byetta side effects after taking this diabetes medication and representing individuals diagnosed with cancer in filing Byetta lawsuit claims nationwide.

It has recently been reported that the medication Byetta (exenatide) which is prescribed to treat diabetes may be linked to an increased risk of developing pancreatic cancer in patients compared to other diabetes therapy options.

In 2011 researchers reported an elevated risk of developing pancreatitis and pancreatic cancer in patients using the diabetes medicine Byetta (generic name – exenatide). Studies examined FDA adverse events reported between 2004 and 2009. Researchers believe that Byetta may unintentially trigger growth in pancreatic gland ducts. They also stressed that more study is needed and the FDA data did not indicate a link between Byetta and any other forms of cancer.

Byetta is manufactured by Amylin Pharmaceuticals, Ind. It was first marketed and sold starting in 2005. Since that time, more than 1 million patients have used Byetta to treat their diabetes. It is estimated more than 10 million prescriptions have been filled for Byetta.

The researchers looked at FDA data for patients taking the drugs exenatide and sitagliptin. This data along with previous animal studies prompted the researchers to suggest that more research needs to be done regarding the link between Byetta and pancreatic cancer.

Pancreatic cancer is one of the leading causes of cancer resulting in death for both men and women and is one of the most deadly of all types of cancer. Current research suggests that the injectable diabetes medication, Byetta, may cause an increased risk of pancreatic cancer in patients using Byetta.

We represent all Byetta lawsuit pancreatic cancer clients on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please call toll free or fill out our short online contact form and a pancreatic cancer lawyer will contact you to answer any of your questions including the latest Byetta lawsuit settlements news. If you have been diagnosed with pancreatic cancer or a loved one has died from pancreatic cancer please contact us as soon as possible. There is a limited time to file a claim.

Featured Byetta Lawsuit News

Byetta and Cancer: Is the Risk of Pancreatic Cancer Worth It?

by Steve Fields on October 1st, 2012

The recent increase in the number of Byetta lawsuit claims being investigated is due, in large part, to complaints of ...
Read More

Byetta Class Action Lawsuit

by Steve Fields on September 15th, 2012

Byetta is the trade name for exenatide, a medication used to treat type II diabetes. Currently there is no Byetta ...
Read More

Byetta Lawsuit Settlements: The Signs Are Often Too Late

by Steve Fields on September 1st, 2012

Manufactured by Amylin Pharmaceuticals and marketed jointly with Eli Lilly and Company, Byetta (exenatide) is prescribed to treat type 2 ...
Read More

Byetta Cancer Risk: Can Pancreatitis Lead To Pancreatic Cancer?

by Steve Fields on August 15th, 2012

There are growing concerns about a possible Byetta cancer risk in related to pancreatic cancer. Approved in 2005, the medication ...
Read More

Researchers Study Link Between Byetta And Pancreatic Cancer

by Steve Fields on July 21st, 2012

Exenatide is the trade name for the diabetes medication Byetta, a drug that has come under increased scrutiny over the ...
Read More